Verification analyses of selected genes within one of the identified deregulated signaling pathways, PLCD1 and PLCE1, confirmed reduced levels of these transcripts in CRC compared to normal mucosa samples. The gene discussed is PLCE1; the disease is colorectal carcinoma.